Clinical trial
Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients With…
NCT00086931 · Roswell Park Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00086931 |
|---|---|
| Title | Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Rectum |
| Official title | A Phase I/II Study of Weekly Intravenous Oxaliplatin in Combination With Oral Daily Capecitabine and Radiation Therapy in the Neoadjuvant Treatment of Rectal Cancer |
| Lead sponsor | Roswell Park Cancer Institute, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | capecitabine, oxaliplatin, conventional surgery, neoadjuvant therapy, radiation therapy |
| Enrollment | 37 |
| Start date | Sep 1, 2003 |
| Primary completion | May 1, 2007 |
| Completion | May 1, 2010 |
| First posted | Jul 12, 2004 |
| Last update posted | Mar 8, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: